(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.14%) $0.928
(0.32%) $10.88
(0.03%) $0.792
(0.02%) $92.60
Live Chart Being Loaded With Signals
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally...
Stats | |
---|---|
Today's Volume | 881 574 |
Average Volume | 134 777 |
Market Cap | 18.24M |
EPS | $0.0100 ( 2023-08-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.86 |
ATR14 | $0.161 (16.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-27 | Robinson James George | Buy | 40 000 | Common Stock |
2023-04-25 | Robinson James George | Buy | 40 000 | Common Stock |
2023-04-25 | Robinson James George | Buy | 40 000 | Common Stock |
2022-05-02 | Robinson James George | Buy | 1 151 515 | Warrant |
2021-04-22 | Robinson James George | Buy | 200 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 1 546 252 | Sell: 0 |
Volume Correlation
Nymox Pharmaceutical Corp Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nymox Pharmaceutical Corp Correlation - Currency/Commodity
Nymox Pharmaceutical Corp Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0735 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0122 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0153 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0502 |
Financial Reports:
No articles found.
Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators